IP Library Granted Patent US 9,095,431
Granted Patent B2
US 9,095,431 · App. 13/519,930 · Granted Aug 4, 2015

Invasive cardiac valve

Inventors: Qifeng Yu (Shanghai, CN); Xiang Liu (Shanghai, CN); Yunlei Wang (Shanghai, CN); Chengyun Yue (Shanghai, CN); Qiyi Luo (Shanghai, CN)
Assignee: SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
A61F2/2412A61F2/2415A61F2/2418A61F2002/3021A61F2220/0075A61F2230/008A61F2230/0023A61F2230/0054A61F2230/0067
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,095,431
App. No.
13/519,930
Granted
Aug 4, 2015
Kind
B2
Abstract

An invasive cardiac valve comprises a tubular stent ( 1 ) and a valve ( 2 ). One end of the tubular stent ( 1 ) is of a frusto-conical structure, the other end is wide open, and the diameter of the open end is greater than the diameter of the frusto-conical end. The valve ( 2 ) is attached to the frusto-conical end of the tubular stent ( 1 ); and a delivery and retrieval hole ( 4 ) of the cardiac valve is provided at the top of the open end of the tubular stent ( 1 ). Because the diameter of the open end is greater than the diameter of the frusto-conical end, the cardiac valve can be effectively fixed in a position of aortic annulus to prevent the cardiac valve displacement caused by the impact of the blood flow. Because the valve ( 2 ) is attached to the frusto-conical end of the tubular stent ( 1 ), the valve ( 2 ) can totally avoid the left and right coronary ostia and does not affect the haemodynamics of the coronary artery. Because a delivery and retrieval hole ( 4 ) of the cardiac valve is provided at the top of the open end of the tubular stent ( 1 ), the cardiac valve can be retrieved and reset at any time by handle control if it is found to be placed in an improper position during the release process.

Claims (22)

1. An invasive cardiac valve having a top end and a bottom end, comprising a tubular stent and a valve, characterized in that

a first portion of the tubular stent is of a frusto-conical structure and defines a first end, a second portion of the tubular stent defines a wide open second end, the second portion of the tubular stent includes three rhombic grids which expand towards the second end in a petal shape, and the diameter of the second end is greater than the diameter of the first end, wherein the three rhombic grids of the tubular stent are composed of stent rods, and the thickness of the stent rods gradually decreases from the second end to the first end;

the valve is attached to the first end of the tubular stent;

a delivery and retrieval hole of the cardiac valve is provided at the second end of the tubular stent, wherein there are three delivery and retrieval holes of the cardiac valve, which are provided at the second end of the three rhombic grids respectively;

a frusto-cone generatrix of the first end of the tubular stent is a straight line, a circular arc or a combination of a straight line and a circular arc;

the cardiac valve defines at least two stent units, the at least two stent units gradually becoming smaller from the top end to the bottom end;

the valve is embodied as a leaflet and a skirt, and the leaflet and the skirt are designed as an integral structure;

the valve is sewed on the grids of the tubular stent, and a middle part of the valve is sewed with a transverse arc line using a suture line; and

the transverse arc line is sutured with the grids of the stent.

2. The invasive cardiac valve according to claim 1 , characterized in that the tubular stent is of a grid structure composed of a plurality of rhombic stent units.

3. The invasive cardiac valve according to claim 1 , characterized in that the portions of the rhombic grids positioned at the second end and at a location spaced from the second end are of an open structure, and the portion of the rhombic grids of the tubular stent between the second end and the location spaced from the second end are of a closed structure.

4. The invasive cardiac valve according to claim 1 , characterized in that each of the three rhombic grids at the second end has a size that is greater than the diameter of the left and right coronary arteries.

5. The invasive cardiac valve according to claim 1 , characterized in that the tubular stent is made of a nickel-titanium alloy material.

6. The invasive cardiac valve according to claim 1 , characterized in that the valve is fixed inside the tubular stent by means of sewing using a suture line.

7. The invasive cardiac valve according to claim 1 , characterized in that the leaflet and the skirt can be made of a biological tissue, a polymer material, a metallic material or a tissue engineered valve.

8. The invasive cardiac valve according to claim 1 , characterized in that the skirt is of a frusto-conical shape sewed by three skirt base bodies of a same trapezoidal shape.

9. The invasive cardiac valve according to claim 1 , characterized in that the valve can be made of a biological tissue, a polymer material, a metallic material or a tissue engineered valve.

10. The invasive cardiac valve according to claim 1 , characterized in that the valve is formed by three valve base bodies of the same shape;

at one end of the valve base body, both sides are provided with leaflet suture ears, which are sewed on the tubular stent;

roots of any two adjacent leaflet suture ears are sewed together.

11. The invasive cardiac valve according to claim 1 , characterized in that the tubular stent further includes a plurality of grids including the three rhombic grids.

12. The invasive cardiac valve according to claim 1 , characterized in that the cardiac valve further includes a plurality of grids including the three rhombic grids.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 3, 2016
From: SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
To: SHANGHAI MICROPORT CARDIOFLOW MEDTECH CO., LTD.
Reel/Frame 040206/0930 →
CHANGE OF NAME Recorded Jan 15, 2013
From: MICROPORT MEDICAL (SHANGHAI) CO., LTD.
To: SHANGHAI MICROPORT MEDICAL (GROUP) CO., LTD.
Reel/Frame 029628/0033 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 12, 2012
From: YU, QIFENG; LIU, XIANG; WANG, YUNLEI; YUE, CHENGYUN; LUO, QIYI
To: MICROPORT MEDICAL (SHANGHAI) CO., LTD
Reel/Frame 028534/0582 →
Priority Claims (1)
CN 2009 1 0248065 · Dec 30, 2009 · national
Continuity (1)
Related Publication 20120316642A1 · Dec 13, 2012